Precision Medicine

A new study from the laboratory of Cody Siciliano suggests that two widely used medications for alcohol use disorder—naltrexone and nalmefene—may be equally effective overall but individuals only respond to one of the two medications. The findings could help explain why clinical trials of naltrexone and nalmefene have produced conflicting results and may point toward a precision-medicine strategy for treating alcohol use disorder. Read More

A Middle Tennessee native, Chase Spurlock, PhD’14, was drawn to Vanderbilt University for its excellence in healthcare and science. A project he completed in graduate school ignited in him a desire to impact patient lives through academic-industry partnerships, and he has not looked back since. Read More

Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference. Approximately 2,500 people from more than 30 countries are registered for the three-day meeting, to be held in Santa Clara,… Read More

by Tom Wilemon A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14 in Cell, describes findings from a single-cell transcriptomic and imaging atlas… Read More